Purification and characterization of secretory clusterin proteins from an eukaryotic expression system and the preliminary exploration of its functions

Tumor

Volumn 33, Issue 7, 2013, Pages 597-603

  Ma, X ^a   Luo, X Y ^b   Zhu, X L ^a   Li, Z H ^b   Li, H C ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Epithelialmesenchymal transition; Eukaryotic expression vector; Purified protein; Secretory clusterin

Indexed keywords

CLUSTERIN; SECRETORY CLUSTERIN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; EUKARYOTE; EXPRESSION VECTOR; GENE EXPRESSION SYSTEM; LUNG CANCER; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE;

EID: 84883043017     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2013.07.005     Document Type: Article

References (19)

1. ROSENBERG M E, SILKENSEN J. Clusterin: P h y s i o l o g i c a n d p a t h o p h y s i o l o g i c considerations[J]. Int J Biochem Cell Biol, 1995, 27(7):633-645.
2. REDDY K B, J IN G, KARODE M C, e t a l Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/ clusterin in epithelial cells[J]. Biochemistry, 1996, 35(19):6157-6163.
3. LAKINS J, BENNETT S A, CHEN J H, et al Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate[J]. J Biol Chem, 1998, 273(43):27887-27895.
4. YANG C R, LESKOV K, HOSLEY-EBERLEIN K, et al Nuclear clusterin/XIP8, an X-ray-induced Ku70-binding protein that signals cell death[J]. Proc Natl Acad Sci U S A, 2000, 97(11):5907-5912.
5. JONES S E, JOMARY C. Clusterin[J]. Int J Biochem Cell Biol, 2002, 34(5):427-431.
6. O'SULLIVAN J, WHYTE L, DRAKE J, et al Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis[J]. Cell Death Differ, 2003, 10(8):914-927.
7. CUCCO C, CALABRETTA B. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides[J]. Cancer Res, 1996, 56(19):4332-4337.
8. ALBERT J M, GONZALEZ A, MASSION P P, et al Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer[J]. Cancer Epidemiol Biomarkers Prev, 2007, 16(9):1845-1851.
9. L I H, L I U S, Z H U X, e t a l C l u s t e r i n immunoexpression and its clinical significance in patients with non-small cell lung cancer[J]. Lung, 2010, 188(5):423-431.
10. KAPOOR S. Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors[J]. Cancer Chemother Pharmacol, 2013, 71(4):1101.
11. NIU Z, LI X, HU B, et al Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer[J]. Acta Biochim Biophys Sin (Shanghai) , 2012, 44(12):991-998.
12. SAAD F, HOTTE S, NORTH S, et al Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c[J]. Clin Cancer Res, 2011, 17(17):5765-5773.
13. BANEYX F, MUJACIC M. Recombinant protein folding and misfolding in Escherichia coli[J]. Nat Biotechnol, 2004, 22(11):1399-1408.
14. CHOU T Y, CHEN W C, LEE A C, et al Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway[J]. Cell Signal, 2009, 21(5):704-711.
15. CHENG C Y, CHERNG S H, WU W J, et al Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells[J]. Cancer Chemother Pharmacol, 2012, 69(1):145-154.
16. LENFERINK A E, MAGOON J, CANTIN C, et al Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: Identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition[J]. Breast Cancer Res, 2004, 6(5): R514-R530.
17. LENFERINK A E, CANTIN C, NANTEL A, et al Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies[J]. Oncogene, 2010, 29(6):831-844.
18. KALLURI R, WEINBERG R A. The basics of epithelialmesenchymal transition[J]. J Clin Invest, 2009, 119(6):1420-1428.
19. MANI S A, GUO W, LIAO M J, et al The epithelialmesenchymal t rans i t ion generates cel l s with properties of stem cells[J]. Cell, 2008, 133(4):704-715.